Metagenomi Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | — | — | $190.5M |
| FY2023 | $149.7M | $364.8M | $140.6M |
| FY2024 | $89.7M | $324.6M | $27.4M |
| FY2025 | $62.5M | $221.1M | $41.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | — | — | $190.5M |
| FY2023 | $149.7M | $364.8M | $140.6M |
| FY2024 | $89.7M | $324.6M | $27.4M |
| FY2025 | $62.5M | $221.1M | $41.7M |